Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity
635 artigos
Japanese trial shows dual HER2 blockade with pertuzumab plus trastuzumab improves overall survival even after prior pertuzumab treatment.
Real-world study of 664 patients reveals effective treatment options after T-DXd discontinuation, with low lung disease recurrence rates.
Large study reveals cancer survivors have higher biological age than cancer-free individuals, with strongest mortality predictions from epigenetic clocks.
Scientists discover how breast cancer builds deadly metastases using a 3D branching pattern, revealing new treatment targets.
Updated guidelines recommend cholesterol screening in childhood and tracking genetic factors like lipoprotein(a) for personalized prevention.
Rare genetic syndrome caused by TP53 mutations leads to extraordinarily high lifetime cancer risk, with new prevention strategies emerging.
Revolutionary blood tests can detect cancer DNA fragments, enabling earlier diagnosis and better treatment monitoring.
New immunotherapies and targeted drugs show promise for treating aggressive hepatobiliary cancers through innovative approaches.
New research shows brief fasting periods can boost the effectiveness of cancer immunotherapy by reshaping tumor-fighting immune cells.
Scientists develop innovative immunotherapy that reprograms multiple immune cell types to attack cancer while reducing side effects.
Researchers develop monoclonal antibody that specifically inhibits heparanase, reducing tumor growth and metastasis in multiple cancer types.
Revolutionary AI-powered chip identifies cancer biomarkers in blood with unprecedented accuracy, potentially transforming early detection.
